KFDA say, no safety problems with plasma fraction products.

Published: 2005-09-09 06:59:00

Updated: 2005-09-09 06:59:00

The KFDA responded to the issues raised by Rep. Ko Gyeong-wha concerning the HIV infected blood preparations in the market on Sept. 5 that the plasma fraction products of the HIV injected blood had no any safety problems because most of virus should be eradicated in the manufacturing process.

...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK